4//SEC Filing
Szot Matthew K 4
Accession 0001213900-25-103147
CIK 0001937993other
Filed
Oct 27, 8:00 PM ET
Accepted
Oct 28, 5:00 PM ET
Size
6.3 KB
Accession
0001213900-25-103147
Insider Transaction Report
Form 4
Szot Matthew K
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-10-24$13.99/sh−1,800$25,182→ 11,733 total - Sale
Common Stock
2025-10-27$13.99/sh−1,800$25,182→ 9,933 total
Footnotes (1)
- [F1]Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on May 9, 2025.
Documents
Issuer
Cadrenal Therapeutics, Inc.
CIK 0001937993
Entity typeother
Related Parties
1- filerCIK 0001401385
Filing Metadata
- Form type
- 4
- Filed
- Oct 27, 8:00 PM ET
- Accepted
- Oct 28, 5:00 PM ET
- Size
- 6.3 KB